Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma

Detalhes bibliográficos
Autor(a) principal: Tsilimigras, DI
Data de Publicação: 2021
Outros Autores: Sahara, K, Paredes, AZ, Moro, A, Mehta, R, Moris, D, Guglielmi, A, Aldrighetti, L, Weiss, M, Bauer, TW, Alexandrescu, S, Poultsides, GA, Maithel, SK, Marques, HP, Martel, G, Pulitano, C, Shen, F, Soubrane, O, Koerkamp, BG, Endo, I, Pawlik, TM
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4366
Resumo: Background: The objective of the current study was to develop a model to predict the likelihood of occult lymph node metastasis (LNM) prior to resection of intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent hepatectomy for ICC between 2000 and 2017 were identified using a multi-institutional database. A novel model incorporating clinical and preoperative imaging data was developed to predict LNM. Results: Among 980 patients who underwent resection of ICC, 190 (19.4%) individuals had at least one LNM identified on final pathology. An enhanced imaging model incorporating clinical and imaging data was developed to predict LNM ( https://k-sahara.shinyapps.io/ICC_imaging/ ). The performance of the enhanced imaging model was very good in the training data set (c-index 0.702), as well as the validation data set with bootstrapping resamples (c-index 0.701) and outperformed the preoperative imaging alone (c-index 0.660). The novel model predicted both 5-year overall survival (OS) (low risk 48.4% vs. high risk 18.4%) and 5-year disease-specific survival (DSS) (low risk 51.9% vs. high risk 25.2%, both p < 0.001). When applied among Nx patients, 5-year OS and DSS of low-risk Nx patients was comparable with that of N0 patients, while high-risk Nx patients had similar outcomes to N1 patients (p > 0.05). Conclusion: This tool may represent an opportunity to stratify prognosis of Nx patients and can help inform clinical decision-making prior to resection of ICC.
id RCAP_f4cc95300aa77919806cac0e35f5a7f1
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4366
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Predicting Lymph Node Metastasis in Intrahepatic CholangiocarcinomaLymph nodeMetastasisIntrahepatic cholangiocarcinomaHCC CIRBackground: The objective of the current study was to develop a model to predict the likelihood of occult lymph node metastasis (LNM) prior to resection of intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent hepatectomy for ICC between 2000 and 2017 were identified using a multi-institutional database. A novel model incorporating clinical and preoperative imaging data was developed to predict LNM. Results: Among 980 patients who underwent resection of ICC, 190 (19.4%) individuals had at least one LNM identified on final pathology. An enhanced imaging model incorporating clinical and imaging data was developed to predict LNM ( https://k-sahara.shinyapps.io/ICC_imaging/ ). The performance of the enhanced imaging model was very good in the training data set (c-index 0.702), as well as the validation data set with bootstrapping resamples (c-index 0.701) and outperformed the preoperative imaging alone (c-index 0.660). The novel model predicted both 5-year overall survival (OS) (low risk 48.4% vs. high risk 18.4%) and 5-year disease-specific survival (DSS) (low risk 51.9% vs. high risk 25.2%, both p < 0.001). When applied among Nx patients, 5-year OS and DSS of low-risk Nx patients was comparable with that of N0 patients, while high-risk Nx patients had similar outcomes to N1 patients (p > 0.05). Conclusion: This tool may represent an opportunity to stratify prognosis of Nx patients and can help inform clinical decision-making prior to resection of ICC.SpringerlinkRepositório do Centro Hospitalar Universitário de Lisboa Central, EPETsilimigras, DISahara, KParedes, AZMoro, AMehta, RMoris, DGuglielmi, AAldrighetti, LWeiss, MBauer, TWAlexandrescu, SPoultsides, GAMaithel, SKMarques, HPMartel, GPulitano, CShen, FSoubrane, OKoerkamp, BGEndo, IPawlik, TM2023-01-31T10:28:01Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4366engJ Gastrointest Surg . 2021 May;25(5):1156-116310.1007/s11605-020-04720-5info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:46:16Zoai:repositorio.chlc.min-saude.pt:10400.17/4366Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:41.617984Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
title Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
spellingShingle Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
Tsilimigras, DI
Lymph node
Metastasis
Intrahepatic cholangiocarcinoma
HCC CIR
title_short Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
title_full Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
title_fullStr Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
title_full_unstemmed Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
title_sort Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma
author Tsilimigras, DI
author_facet Tsilimigras, DI
Sahara, K
Paredes, AZ
Moro, A
Mehta, R
Moris, D
Guglielmi, A
Aldrighetti, L
Weiss, M
Bauer, TW
Alexandrescu, S
Poultsides, GA
Maithel, SK
Marques, HP
Martel, G
Pulitano, C
Shen, F
Soubrane, O
Koerkamp, BG
Endo, I
Pawlik, TM
author_role author
author2 Sahara, K
Paredes, AZ
Moro, A
Mehta, R
Moris, D
Guglielmi, A
Aldrighetti, L
Weiss, M
Bauer, TW
Alexandrescu, S
Poultsides, GA
Maithel, SK
Marques, HP
Martel, G
Pulitano, C
Shen, F
Soubrane, O
Koerkamp, BG
Endo, I
Pawlik, TM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Tsilimigras, DI
Sahara, K
Paredes, AZ
Moro, A
Mehta, R
Moris, D
Guglielmi, A
Aldrighetti, L
Weiss, M
Bauer, TW
Alexandrescu, S
Poultsides, GA
Maithel, SK
Marques, HP
Martel, G
Pulitano, C
Shen, F
Soubrane, O
Koerkamp, BG
Endo, I
Pawlik, TM
dc.subject.por.fl_str_mv Lymph node
Metastasis
Intrahepatic cholangiocarcinoma
HCC CIR
topic Lymph node
Metastasis
Intrahepatic cholangiocarcinoma
HCC CIR
description Background: The objective of the current study was to develop a model to predict the likelihood of occult lymph node metastasis (LNM) prior to resection of intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent hepatectomy for ICC between 2000 and 2017 were identified using a multi-institutional database. A novel model incorporating clinical and preoperative imaging data was developed to predict LNM. Results: Among 980 patients who underwent resection of ICC, 190 (19.4%) individuals had at least one LNM identified on final pathology. An enhanced imaging model incorporating clinical and imaging data was developed to predict LNM ( https://k-sahara.shinyapps.io/ICC_imaging/ ). The performance of the enhanced imaging model was very good in the training data set (c-index 0.702), as well as the validation data set with bootstrapping resamples (c-index 0.701) and outperformed the preoperative imaging alone (c-index 0.660). The novel model predicted both 5-year overall survival (OS) (low risk 48.4% vs. high risk 18.4%) and 5-year disease-specific survival (DSS) (low risk 51.9% vs. high risk 25.2%, both p < 0.001). When applied among Nx patients, 5-year OS and DSS of low-risk Nx patients was comparable with that of N0 patients, while high-risk Nx patients had similar outcomes to N1 patients (p > 0.05). Conclusion: This tool may represent an opportunity to stratify prognosis of Nx patients and can help inform clinical decision-making prior to resection of ICC.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2023-01-31T10:28:01Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4366
url http://hdl.handle.net/10400.17/4366
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv J Gastrointest Surg . 2021 May;25(5):1156-1163
10.1007/s11605-020-04720-5
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springerlink
publisher.none.fl_str_mv Springerlink
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131311883943936